Nootropic Peptides

Educational reference only — not medical advice. Compounds with no UK marketing authorisation and no other lawful UK use (for example as a food supplement or cosmetic ingredient) are not for human consumption; this describes UK status only.
Head to head

Pinealon vs Epitalon

Pinealon and Epitalon are the two flagship Khavinson-school short bioregulator peptides on this site. Both come out of the same St. Petersburg Institute of Bioregulation and Gerontology programme, both are proposed to act as direct DNA-binding transcriptional regulators, and both feature in the Russian gerontology and cognitive-ageing research literature. But they are positioned differently — Pinealon as a neuroprotective bioregulator, Epitalon as a pineal-targeted gerontoprotective peptide — and understanding the distinction matters for research-context selection.

At a glance

PinealonEpitalon
SequenceGlu-Asp-Arg (tripeptide)Ala-Glu-Asp-Gly (tetrapeptide)
Molecular target framingNeuroprotective bioregulatorPineal-targeted bioregulator
Primary endpointAntioxidant / neuroprotective in oxidative-stress modelsTelomerase induction / circadian restoration
Signature research findingPreserved neuronal viability under hypoxic/oxidative challengeExtension of replicative lifespan in cultured cells; melatonin-rhythm restoration
Institutional originSt. Petersburg Institute of Bioregulation and Gerontology (Khavinson)Same institute, same programme
Cognitive relevanceDirect — neuroprotection in cognitive-ageing modelsIndirect — via circadian and stress-resilience mechanisms
RouteIntranasal / parenteralIntranasal / parenteral (subcutaneous most common)
Typical research cycleNo sourced cycle lengthNo sourced cycle length
UK statusNo emc entry found (checked 17 October 2026)No emc entry found (checked 17 October 2026)
Evidence tierB (Russian clinical experience)B (Russian clinical + cohort data)

The distinction

Same programme, different targets

Pinealon

Pinealon is a three-amino-acid peptide (Glu-Asp-Arg) positioned in the Khavinson framework as a neuroprotective bioregulator. Its research signature is antioxidant enzyme upregulation, reduction of reactive oxygen species accumulation under oxidative and hypoxic challenge, and preservation of neuronal viability in cellular and in-vivo neuroprotection models. It is the more directly cognitive-relevant of the two peptides in the sense that its primary endpoint is CNS neuronal protection.

Epitalon

Epitalon is a four-amino-acid peptide (Ala-Glu-Asp-Gly) positioned as a pineal-targeted bioregulator with distinctive telomerase-induction and circadian- restoration effects. Its most-cited findings are cellular (telomerase activity in cultured fibroblasts, extension of replicative lifespan) and organismal (melatonin-rhythm restoration in aged animals, long-term-cohort gerontoprotective effects). Cognitive relevance is indirect — via circadian regulation and stress-axis attenuation rather than direct neuroprotection.

Combined use

When to use both

The two peptides are commonly studied together in Russian gerontology and cognitive-ageing research designs. The Khavinson practice framework routinely uses multiple bioregulators in the same protocol — the theoretical rationale being that short peptides target specific gene-expression programmes without cross-talk, so combining bioregulators addressing different endpoints doesn't produce the redundancy or interference that combining two compounds targeting the same receptor would.

For research-context selection, the choice is straightforward: Pinealon for cognitive-relevant neuroprotection under oxidative or ischaemic challenge (particularly in cognitive-ageing models), Epitalon for circadian-cognition research designs and gerontoprotective protocols, and both together when a research design needs both arms of the Khavinson approach — which is the more common configuration in the published Russian work.